Kevin McRae‐McKee

Twenty-seven-year time trends in dementia incidence in Europe and the United States

Frank J. Wolters, Lori B. Chibnik, Reem Waziry et al. · Neurology · 2020 · 476 citations · Full text

Medicine, Geriatric Medicine, Neurology +13

Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study

Frank de Wolf, Mohsen Ghanbari, Silvan Licher et al. · Brain · 2020 · 339 citations · Full text

Medicine, Geriatric Medicine, Neurology +17

The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease

Christoforos Hadjichrysanthou, Stephanie Evans, Sumali Bajaj et al. · Alzheimer s Research & Therapy · 2020 · 89 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer’s disease neuropathology

David X. Thomas, Sumali Bajaj, Kevin McRae‐McKee et al. · Scientific Reports · 2020 · 51 citations · Full text

Medicine, Neurology, Neuroscience +17

The importance of endpoint selection: How effective does a drug need to be for success in a clinical trial of a possible Alzheimer’s disease treatment?

Stephanie Evans, Kevin McRae‐McKee, Mei Mei Wong et al. · European Journal of Epidemiology · 2018 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15